Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group – Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

Updated: Oct 1, 2022

Cureline Baltic COO  has presented Cureline Group – Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

Thank you  Innovation Agency Lithuania and Embassy of Lithuania to S. Korea team for organizing opportunity to visit Seoul and meet our potential partners and clients.

          

Lithuanian biotech group develops closer ties with Korea’s biotech industry < Bio < 기사본문 – KBR

The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high value-added technologies.In an interview with Korea Biome.
www.koreabiomed.com

Lithuania continues to expand international partnerships in the field of biotechnology – Lithuania

Lithuania continues to expand international partnerships! This time establishing collaboration with South Korea. South Korea is one of the world leaders in the field of biotechnology, especially in the development and production of pharmaceuticals and medical devices.
lithuania.lt

On August 3-5, the Business Mission of Lithuanian Biotechnologies took place in South Korea – LBTA

Lithuania continues to expand international partnerships! This time establishing collaboration with South Korea. South Korea is one of the world leaders in the field of biotechnology, especially in the development and production of pharmaceuticals and medical devices. This country is one of Lithuania’s priority markets, so we aim to strengthen relations between the two countries…
lbta.lt

Loading

Categories

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US





Additional Information: